Biocryst Pharmaceuticals reported $263.66M in Loan Capital for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Loan Capital Change
Alexion Pharmaceuticals ALXN:US $ 2388.8M 30.8M
Alnylam Pharmaceuticals ALNY:US $ 433.15M 241.56M
Biocryst Pharmaceuticals BCRX:US $ 263.66M 9.32M
Chemocentryx CCXI:US $ 11.57M 3.3M
Daiichi Sankyo 4568:JP Y 163347M 33148M
GlaxoSmithKline GSK:LN 20442M 2605M
Glaxosmithkline GSK:US $ 20442M 2605M
Intra Cellular Therapies ITCI:US $ 0M 0M
IONIS PHARMACEUT IONS:US $ 1240.7M 369.78M
Karyopharm Therapeutics KPTI:US $ 301.38M 59.58M
Mirati Therapeutics MRTX:US $ 0M 0M
Neurocrine Biosciences NBIX:US $ 326.3M 4.3M
Novavax NVAX:US $ 331.94M 7.15M
Ptc Therapeutics PTCT:US $ 1115.38M 3.45M
Regeneron Pharmaceuticals REGN:US $ 1979.2M 0.3M
Sarepta Therapeutics SRPT:US $ 1092.98M 1.88M
Ultragenyx Pharmaceutical RARE:US $ 0M 0M
Vertex Pharmaceuticals VRTX:US $ 524.92M 5.4M
YTE INCY:US $ 31.84M 0.32M
Zogenix ZGNX:US $ 153.63M 2.18M